When a woman is diagnosed with breast cancer, one of the major things that she might be concerned about is her future fertility after her cancer goes away. It has been common knowledge for many years that cancer treatments like chemotherapy can really damage a woman’s fertility and make it impossible for her to get pregnant down the line. Claim Your 20 Free Pregnancy Tests – Click Here
However, a new drug called Zoladex is changing all of that and making it possible for women’s fertility to be preserved if it is taken in conjunction with chemotherapy. A study suggests that women diagnosed with hormone-receptor-negative, early-stage breast cancer who were treated with Zoladex (chemical name: goserelin) in addition to chemotherapy before surgery were much less likely to be infertile after chemotherapy ended.
Essentially, Zoladex is able to “shut down” the ovaries in order to preserve women’s fertility on down the line. If a woman is diagnosed with cancer and is thinking about undergoing chemotherapy, it is a good idea for her to talk to her doctor to see if Zoladex might be an option that could be used in order to help improve fertility. Zoladex is a great option and many women could really benefit from using Zoladex to improve their fertility.